Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1757 (LINC01757) is a human long intergenic non-coding RNA (lincRNA) locus that produces long, non-coding RNAs (>200 nucleotides) and does not overlap with annotated protein-coding genes[7][1][3]. LincRNAs are a subclass of long non-coding RNAs, often functioning in the regulation of gene transcription, chromatin organization, and RNA stability in a highly cell type- and context-specific manner[1][3][5]. While some lincRNAs have been implicated in disease or as regulators of gene expression, there is currently no evidence that LINC01757 itself acts as a receptor, enzyme, or other established drug target, nor is it specifically linked to disease or targeted by known drugs[7].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1757 (LINC01757).